The Liquid Biopsy Hematology Profile uses cell-free DNA (cfDNA) for detecting abnormalities in hematologic diseases and for monitoring minimal residual disease (MRD). The Liquid Biopsy Hematology Profile is designed and offered to reduce the need for a bone marrow biopsy. It is highly useful for patients presenting with cytopenia and to rule out MDS/CMML, MPN or other hematologic neoplasms. It can also be used for monitoring patients with hematologic neoplasms and therapeutic response.